Alternative Roles for CRISPR/Cas Systems in Bacterial Pathogenesis

PLoS Pathogens

Volumn 9, Issue 10, 2013, Pages

  Sampson, Timothy R ^a,b   Weiss, David S ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN; MESSENGER RNA; NUCLEIC ACID; PALINDROMIC DNA; TOLL LIKE RECEPTOR 2;

ARTICLE; AUTOIMMUNITY; BACTERIAL PATHOGENESIS; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL VIRULENCE; CRISPR CAS SYSTEM; DEFENSE MECHANISM; DNA DAMAGE; DNA REPAIR; GENE CONTROL; GENETIC DATABASE; PATHOGENESIS; PROTEIN TRANSPORT;

BACTERIA; BACTERIAL INFECTIONS; BACTERIAL PROTEINS; DNA-BINDING PROTEINS; RNA-BINDING PROTEINS; VIRULENCE FACTORS;

EID: 84887272267     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003621     Document Type: Article

References (20)

1. Makarova KS, Haft DH, Barrangou R, Brouns SJ, Charpentier E, et al. (2011) Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol 9: 467-477.
2. Deltcheva E, Chylinski K, Sharma CM, Gonzales K, Chao Y, et al. (2011) CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471: 602-607.
3. Yosef I, Goren MG, Qimron U, (2012) Proteins and DNA elements essential for the CRISPR adaptation process in Escherichia coli. Nucleic Acids Res 40: 5569-5576.
4. Datsenko KA, Pougach K, Tikhonov A, Wanner BL, Severinov K, et al. (2012) Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system. Nat Commun 3: 945.
5. Sampson TR, Saroj SD, Llewellyn AC, Tzeng YL, Weiss DS, (2013) A CRISPR/Cas system mediates bacterial innate immune evasion and virulence. Nature 497: 254-257.
6. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, et al. (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337: 816-821.
7. Gasiunas G, Barrangou R, Horvath P, Siksnys V, (2012) Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci U S A 109: E2579-2586.
8. Louwen R, Horst-Kreft D, de Boer AG, van der Graaf L, de Knegt G, et al. (2013) A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain-Barré syndrome. Eur J Clin Microbiol Infect Dis 32: 207-226.
9. Gunderson FF, Cianciotto NP, (2013) The CRISPR-associated gene cas2 of Legionella pneumophila is required for intracellular infection of amoebae. MBio 4: e00074-00013.
10. Abu Kwaik Y, Gao LY, Stone BJ, Venkataraman C, Harb OS, (1998) Invasion of protozoa by Legionella pneumophila and its role in bacterial ecology and pathogenesis. Appl Environ Microbiol 64: 3127-3133.
11. Cady KC, O'Toole GA, (2011) Non-identity-mediated CRISPR-bacteriophage interaction mediated via the Csy and Cas3 proteins. J Bacteriol 193: 3433-3445.
12. Zegans ME, Wagner JC, Cady KC, Murphy DM, Hammond JH, et al. (2009) Interaction between bacteriophage DMS3 and host CRISPR region inhibits group behaviors of Pseudomonas aeruginosa. J Bacteriol 191: 210-219.
13. Babu M, Beloglazova N, Flick R, Graham C, Skarina T, et al. (2011) A dual function of the CRISPR-Cas system in bacterial antivirus immunity and DNA repair. Mol Microbiol 79: 484-502.
14. Suvarnapunya AE, Lagasse HA, Stein MA, (2003) The role of DNA base excision repair in the pathogenesis of Salmonella enterica serovar Typhimurium. Mol Microbiol 48: 549-559.
15. Stern A, Keren L, Wurtzel O, Amitai G, Sorek R, (2010) Self-targeting by CRISPR: gene regulation or autoimmunity? Trends Genet 26: 335-340.
16. Jorth P, Whiteley M, (2012) An evolutionary link between natural transformation and CRISPR adaptive immunity. MBio 3: e00309-12.
17. Vercoe RB, Chang JT, Dy RL, Taylor C, Gristwood T, et al. (2013) Cytotoxic chromosomal targeting by CRISPR/Cas systems can reshape bacterial genomes and expel or remodel pathogenicity islands. PLoS Genet 9: e1003454 doi:10.1371/journal.pgen.1003454.
18. Westra ER, Brouns SJ, (2012) The rise and fall of CRISPRs-dynamics of spacer acquisition and loss. Mol Microbiol 85: 1021-1025.
19. Qi LS, Larson MH, Gilbert LA, Doudna JA, Weissman JS, et al. (2013) Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152: 1173-1183.
20. Cady KC, Bondy-Denomy J, Heussler GE, Davidson AR, O'Toole GA, (2012) The CRISPR/Cas adaptive immune system of Pseudomonas aeruginosa mediates resistance to naturally occurring and engineered phages. J Bacteriol 194: 5728-5738.